Fragile X syndrome therapeutics S(C)TEP through the developmental window

May 31, 2012
Aditi Bhattacharya and Eric Klann http://www.ncbi.nlm.nih.gov/pubmed/22500622 ...
Read More

Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice

October 22, 2012
Aditi Bhattacharya, Hanoch Kaphzan, Amanda C. Alvarez-Dieppa, Jacyln P. Murphy, Philippe Pierre, and Eric Klann http://www.cell.com/neuron/abstract/S0896-6273(12)00673-3?switch=standard ...
Read More

The translation of translational control by FMRP: therapeutic targets for FXS

April 18, 2013
Jennifer C. Darnell, and Eric Klann http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3379.html De novo protein synthesis is necessary for long-lasting modifications in synaptic strength and dendritic spine dynamics that underlie cognition. Fragile X syndrome (FXS), characterized by intellectual disability...
Read More

(Li+)ghting the way for a treatment for cognitive impairments in fragile X syndrome

May 5, 2014
Aditi Bhattacharya and Eric Klann http://www.ncbi.nlm.nih.gov/pubmed/24370350  ...
Read More

Dysregulation and restoration of translational homeostasis in fragile X syndrome.

October 8, 2015
Joel D. Richter, Gary J. Bassell & Eric Klann http://www.ncbi.nlm.nih.gov/pubmed/26350240 ...
Read More

Aditi Bhattacharya and Eric Klann

http://www.ncbi.nlm.nih.gov/pubmed/22500622